ATS 2021: Mepolizumab Reduces Systemic Corticosteroid Use in Patients With Chronic Rhinosinusitis With Nasal Polyps
Findings were the result of a sub-analysis of the SYNAPSE trial
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.